Sage Therapeutics (NASDAQ:SAGE) PT Lowered to $18.00 : vimarsana.com

Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price objective decreased by stock analysts at Truist Financial from $22.00 to $18.00 in a report released on Friday, Benzinga reports. The firm presently has a “hold” rating on the biopharmaceutical company’s stock. Truist Financial’s target price indicates a potential upside of 31.48% from the stock’s […]

Related Keywords

Texas , United States , China , Switzerland , Swiss , America , , Morgan Stanley , Sage Therapeutics Inc , Nasdaq , China Universal Asset Management Co , Swiss National Bank , Scotiabank , Needham Company , Sage Therapeutics , Get Free Report , Truist Financial , Retirement System , Universal Asset Management , National Bank , Sage Therapeutics Daily , Nasdaq Sage , Sage , Medical , Lower Price Target , Truist Financial Co ,